Platelet‐rich fibrin/aspirin complex promotes alveolar bone regeneration in periodontal defect in rats
Authors:
Open Access
- 1 September 2017
- journal article
- research article
- Published by Wiley in Journal of Periodontal Research
- Vol. 53 (1) , 47-56
Abstract
Background and Objectives: The efficacy and outcomes of aspirin in local defects and the use of platelet‐rich fibrin (PRF) in periodontal defects were investigated. Whether the PRF/aspirin complex is a suitable scaffold and delivery system to carry sustained‐release aspirin/salicylic acid to promote periodontal bone regeneration was determined.Material and Methods: PRF and PRF/aspirin complex were prepared. The concentrations of aspirin/salicylic acid released from the PRF/aspirin complex were calculated at 37°C. Periodontal ligament mesenchymal cells were cultured on six‐well plates with PRF or PRF/aspirin complex gel to analyze proliferation and migration. The alveolar bone between the inferior buccal mesial root and anterior buccal distal root of the first maxillary molar was removed in 15 rats randomly divided into three groups: no treatment, PRF or PRF/aspirin complex. Twelve weeks post‐transplantation, 2D/3D micro‐computed tomography and histomorphometric technique were used for quantitative analyses.Results: The PRF/aspirin complex provided a sustained‐release aspirin/salicylic acid. Peak concentrations occurred 4 hours after transplantation and were sustained to 48 hours at 37°C; the total concentration of released aspirin/salicylic acid was 83.5 mg/mL, respectively. The sustained‐release promoted the proliferation and migration of periodontal ligament mesenchymal cells. Micro‐computed tomography and histological data showed that both the PRF and PRF/aspirin complex enhanced periodontal bone formation (P<.05). Moreover, the new bone formation was two times greater in the PRF/aspirin complex group than the PRF group.Conclusion: Aspirin/salicylic acid could be sustained‐released from PRF/aspirin complex, which could inhibit inflammation and improve the function of mesenchymal cells. The data might provide a new safe and easy clinical therapeutic strategy to promote periodontal bone reparation.Keywords
Funding Information
- National Natural Science Foundation of China (81470751, 81222011)
This publication has 20 references indexed in Scilit:
- Mesenchymal stem cell–based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-αNature Medicine, 2011
- Platelets, inflammation and tissue regenerationThrombosis and Haemostasis, 2011
- Platelet‐rich fibrin membranes as scaffolds for periosteal tissue engineeringClinical Oral Implants Research, 2010
- In vitro effects of Choukroun's PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary culturesOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2009
- Comparison of Surgically Repaired Achilles Tendon Tears Using Platelet-Rich Fibrin MatricesThe American Journal of Sports Medicine, 2007
- Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part IV: Clinical effects on tissue healingOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part III: Leucocyte activation: A new feature for platelet concentrates?Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolutionOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic featuresOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2006
- Platelets are mitogenic for periosteum‐derived cellsJournal of Orthopaedic Research, 2003